Has Shahid Ali, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,766 in general payments to Shahid Ali, MD across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shahid Ali, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shahid Ali, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shahid Ali, MD

Internal Medicine · Philadelphia, PANPI 1538391552

Payments from drug & device makers

$1,766in general payments, 2019–2025

Across 72 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
Pfizer$157
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$119
Novartis$100
Amgen$43

What the payments were for

Food & beverage$1,766100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	51	$1,346
Pfizer	10	$157
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$119
Novartis	7	$100
Amgen	2	$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XARELTO$364

How this compares

$1,766 in reported general payments places this provider in the 80th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$54,284

Medicare patients

241

Services billed

522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CefuroximeCefuroxime Axetil	43	$710
Albuterol Sulfate HfaAlbuterol Sulfate	28	$709
Ventolin HfaAlbuterol Sulfate	12	$663
Azithromycin	12	$101
Atorvastatin Calcium	13	$68
Prednisone	23	$41

Paid to pharmacies, not to this prescriber.

Other internal medicine in Philadelphia

Jonathan EpsteinPhiladelphia$13.1M
Pitamber DevgonPhiladelphia$7.5M
Walter KraftPhiladelphia$3.7M
Daniel RaderPhiladelphia$3.3M
Archna BajajPhiladelphia$2.9M
Gary YeomanPhiladelphia$2.4M
Melina MarmarelisPhiladelphia$2.1M
Adam WaxmanPhiladelphia$894K
Donna GavaronePhiladelphia$728K
Eyob FeyssaPhiladelphia$693K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →